Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03135171
Brief Title: Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab

First Submitted : April 25, 2017
First Submitted that Met QC Criteria : April 25, 2017
First Posted : May 1, 2017

Last Update Submitted that Met QC Criteria : February 7, 2019
Last Update Posted : February 8, 2019